rs113416399

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The ENST00000588558.6(G6PC3):​n.*1018T>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0103 in 1,612,470 control chromosomes in the GnomAD database, including 94 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0069 ( 4 hom., cov: 32)
Exomes 𝑓: 0.011 ( 90 hom. )

Consequence

G6PC3
ENST00000588558.6 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.440

Publications

4 publications found
Variant links:
Genes affected
G6PC3 (HGNC:24861): (glucose-6-phosphatase catalytic subunit 3) This gene encodes the catalytic subunit of glucose-6-phosphatase (G6Pase). G6Pase is located in the endoplasmic reticulum (ER) and catalyzes the hydrolysis of glucose-6-phosphate to glucose and phosphate in the last step of the gluconeogenic and glycogenolytic pathways. Mutations in this gene result in autosomal recessive severe congenital neutropenia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]
G6PC3 Gene-Disease associations (from GenCC):
  • autosomal recessive severe congenital neutropenia due to G6PC3 deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 17-44076045-T-C is Benign according to our data. Variant chr17-44076045-T-C is described in ClinVar as Benign. ClinVar VariationId is 211056.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00691 (1052/152312) while in subpopulation NFE AF = 0.0127 (863/68022). AF 95% confidence interval is 0.012. There are 4 homozygotes in GnomAd4. There are 458 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
G6PC3NM_138387.4 linkc.*2T>C 3_prime_UTR_variant Exon 6 of 6 ENST00000269097.9 NP_612396.1 Q9BUM1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
G6PC3ENST00000269097.9 linkc.*2T>C 3_prime_UTR_variant Exon 6 of 6 1 NM_138387.4 ENSP00000269097.3 Q9BUM1

Frequencies

GnomAD3 genomes
AF:
0.00691
AC:
1052
AN:
152194
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00229
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00327
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00290
Gnomad FIN
AF:
0.00151
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0127
Gnomad OTH
AF:
0.00573
GnomAD2 exomes
AF:
0.00643
AC:
1611
AN:
250448
AF XY:
0.00630
show subpopulations
Gnomad AFR exome
AF:
0.00228
Gnomad AMR exome
AF:
0.00286
Gnomad ASJ exome
AF:
0.000893
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00179
Gnomad NFE exome
AF:
0.0115
Gnomad OTH exome
AF:
0.00848
GnomAD4 exome
AF:
0.0106
AC:
15485
AN:
1460158
Hom.:
90
Cov.:
33
AF XY:
0.0105
AC XY:
7613
AN XY:
726528
show subpopulations
African (AFR)
AF:
0.00206
AC:
69
AN:
33480
American (AMR)
AF:
0.00304
AC:
136
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.000689
AC:
18
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.00250
AC:
216
AN:
86236
European-Finnish (FIN)
AF:
0.00234
AC:
121
AN:
51762
Middle Eastern (MID)
AF:
0.000520
AC:
3
AN:
5768
European-Non Finnish (NFE)
AF:
0.0129
AC:
14363
AN:
1111978
Other (OTH)
AF:
0.00924
AC:
558
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
935
1870
2804
3739
4674
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
540
1080
1620
2160
2700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00691
AC:
1052
AN:
152312
Hom.:
4
Cov.:
32
AF XY:
0.00615
AC XY:
458
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.00229
AC:
95
AN:
41568
American (AMR)
AF:
0.00327
AC:
50
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00290
AC:
14
AN:
4826
European-Finnish (FIN)
AF:
0.00151
AC:
16
AN:
10626
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0127
AC:
863
AN:
68022
Other (OTH)
AF:
0.00567
AC:
12
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
57
114
172
229
286
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00909
Hom.:
4
Bravo
AF:
0.00703
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.0112
EpiControl
AF:
0.00948

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Dec 19, 2016
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

G6PC3-related disorder Benign:1
Mar 16, 2020
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

G6PC3: BS1, BS2 -

Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
2.0
DANN
Benign
0.72
PhyloP100
-0.44
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs113416399; hg19: chr17-42153413; API